December 5, 2022
Full findings from the CLARITY AD trial released last week show that treatment with the monoclonal antibody lecanemab led to modest cognitive benefit in patients with […]
December 5, 2022
NASHVILLE, Tennessee ― Targeting relevant sleep problems for patients with refractory temporal lobe epilepsy (TLE) improves cognition, results of a new, double-blind, randomized controlled trial suggest. […]
December 5, 2022
Hearing aids significantly reduce the risk for cognitive decline and dementia and even improve short-term cognitive function in individuals with hearing loss, a new study suggests. […]
December 2, 2022
Dr Marc Tessier-Lavigne Stanford University has launched a formal investigation into its own president, neuroscientist Marc Tessier-Lavigne, PhD, for alleged research misconduct pertaining to five scientific […]
December 2, 2022
Because of high out-of-pocket costs of new-to-market neurologic drugs that are of similar benefit as older agents, only a small percentage of patients with neurologic disorders […]
December 2, 2022
A recently identified biomarker found in urine could be the first step toward the development of a simple and inexpensive test for early-stage Alzheimer’s disease (AD), […]
December 1, 2022
A large Danish study supports a robust and long-term bidirectional relationship between epilepsy and depression, with implications for diagnosis and patient care. Eva Bølling-Ladegaard The findings […]
November 29, 2022
The first tau biomarkers that have the potential to identify types of frontotemporal lobar degeneration (FTLD) in living patients and facilitate design of clinical trials to […]
November 28, 2022
The study covered in this summary was published on MedRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Participants with premanifest Huntington’s […]